Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aisling M Redmond

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The EMBO Journal|June 25, 2013
Enhancer-derived RNAs: 'spicing up' transcription programsAisling M Redmond, Jason S Carroll
Genome Biology|August 12, 2009
Defining and targeting transcription factors in cancerAisling M Redmond, Jason S Carroll
Plos One|November 21, 2019
Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulationAisling M Redmond, Soleilmane Omarjee, Igor Chernukhin, et al.
Genome Biology|February 19, 2021
LINE retrotransposons characterize mammalian tissue-specific and evolutionarily dynamic regulatory regionsMaša Roller, Ericca Stamper, Diego Villar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrenceAisling M Redmond, Fiona T Bane, Anthony T Stafford, et al.
Endocrine-Related Cancer|May 13, 2008
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patientsMary F Dillon, Anthony T Stafford, Gabrielle Kelly, et al.
Nature Communications|April 17, 2020
A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell divisionLovorka Stojic, Aaron T L Lun, Patrice Mascalchi, et al.
Oncogene|January 26, 2018
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancerAlacoque L Browne, Sara Charmsaz, Damir Varešlija, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic TumorsDamir Varešlija, Jean McBryan, Ailís Fagan, et al.
Communications Biology|April 9, 2022
Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomasAlvin Wei Tian Ng, Gianmarco Contino, Sarah Killcoyne, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The EMBO Journal|June 25, 2013
Enhancer-derived RNAs: 'spicing up' transcription programsAisling M Redmond, Jason S Carroll
Genome Biology|August 12, 2009
Defining and targeting transcription factors in cancerAisling M Redmond, Jason S Carroll
Plos One|November 21, 2019
Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulationAisling M Redmond, Soleilmane Omarjee, Igor Chernukhin, et al.
Genome Biology|February 19, 2021
LINE retrotransposons characterize mammalian tissue-specific and evolutionarily dynamic regulatory regionsMaša Roller, Ericca Stamper, Diego Villar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrenceAisling M Redmond, Fiona T Bane, Anthony T Stafford, et al.
Endocrine-Related Cancer|May 13, 2008
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patientsMary F Dillon, Anthony T Stafford, Gabrielle Kelly, et al.
Nature Communications|April 17, 2020
A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell divisionLovorka Stojic, Aaron T L Lun, Patrice Mascalchi, et al.
Oncogene|January 26, 2018
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancerAlacoque L Browne, Sara Charmsaz, Damir Varešlija, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic TumorsDamir Varešlija, Jean McBryan, Ailís Fagan, et al.
Communications Biology|April 9, 2022
Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomasAlvin Wei Tian Ng, Gianmarco Contino, Sarah Killcoyne, et al.
Pageof 2